1-14 of 14
Anne Lazareth
Close
Sort by
Journal Articles

French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): Update of the IFM Study from the Descar-T Registry

Sarah Cayla, Benoit Ferment, Noemie Bigot, Denis Caillot, Ingrid Lafon, Lionel Karlin, Anne Lazareth, Cyrille Touzeau, Xavier Leleu, Niels Moya, Stephanie Harel, Aurore Perrot, Pierre Bories, Laure Vincent, Sylvain Lamure, Mohamad Mohty, Florent Malard, Salomon Manier, Ibrahim Yakoub-Agha, Anne-Marie Stoppa, Gabriel Brisou, Olivier Decaux, Roch Houot, Steven Le Gouill, Jerome Lambert, Thierry Facon, Herve Avet Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood
Blood (2023) 142 (Supplement 1): 2139.
https://doi.org/10.1182/blood-2023-188655
Published: 2023
Journal Articles

Skeletal Muscle Index, As a Measure of Muscle Mass, Is a Significant Prognostic Factor for Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma Patients

Gabriel Antherieu, Edith Julia, Alizee Maarek, Violaine Safar, Emmanuelle Ferrant, Alexandra Traverse-Glehen, Anne Lazareth, Helene Lequeu, Stéphanie Cordeil, Guillaume Aussedat, Camille Golfier, Dana Ghergus, Pierre Sesques, Lionel Karlin, Fadhela Bouafia Sauvy, Gilles Salles, Emmanuel Bachy, Emmanuel Jouanneau, Francois Ducray, Loic Boussel, Herve Ghesquieres
Journal: Blood
Blood (2023) 142 (Supplement 1): 1764.
https://doi.org/10.1182/blood-2023-179765
Published: 2023
Journal Articles

Evaluation of Participation and Recruitment Bias in a Prospective Real-Life Multicentric Cohort « Real World Data in Lymphoma and Survival in Adults » (REALYSA study) for Newly Diagnosed Lymphoma Patients over One Year in a Hematology Department of Teaching Hospital

Caroline LE Lan, Aurelien Belot, Camille Golfier, Berenice Audin, Pierre Sesques, Adeline Bernier, Violaine Safar, Alexandra Marquet, Emmanuelle Ferrant, Anne Lazareth, Helene Lequeu, Fadhela Bouafia, Lionel Karlin, Dana Ghergus, Alizee Maarek, Guillaume Aussedat, Maryam Idlhaj, Gilles Salles, Fanny Cherblanc, Emmanuel Bachy, Herve Ghesquieres
Journal: Blood
Blood (2022) 140 (Supplement 1): 5210–5211.
https://doi.org/10.1182/blood-2022-164552
Published: 2022
Journal Articles

French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): An IFM Study from the Descar-T Registry

Benoit Ferment, Jérôme Lambert, Denis Caillot, Ingrid Lafon, Lionel Karlin, Anne Lazareth, Cyrille Touzeau, Xavier Leleu, Niels Moya, Stephanie Harel, Aurore Perrot, Pierre Bories, Laure Vincent, Sylvain Lamure, Mohamad Mohty, Florent Malard, Salomon Manier, Ibrahim Yakoub-Agha, Anne-Marie Stoppa, Gabriel Brisou, Olivier Decaux, Roch Houot, Steven Le Gouill, Thierry Facon, Hervé Avet-Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood
Blood (2022) 140 (Supplement 1): 4668–4670.
https://doi.org/10.1182/blood-2022-162682
Published: 2022
Journal Articles

Outcome in Multiple Myeloma Patients Treated in the Era of Modern Therapies Who Were Admitted to Intensive Care: A Retrospective Analysis from a Teaching Hospital between 2014 and 2019

Zofia Gross, Maryam Idlhaj, Lionel Karlin, Arnaud Friggeri, Anne Lazareth, Camille Golfier, Helene Lequeu, Fadhela Bouafia Sauvy, Pierre Sesques, Violaine Safar, Emmanuelle Ferrant, Dana Ghergus, Alizee Maarek, Guillaume Aussedat, Gilles Salles, Emmanuel Bachy, Florent Wallet, Herve Ghesquieres
Journal: Blood
Blood (2022) 140 (Supplement 1): 13099–13101.
https://doi.org/10.1182/blood-2022-165911
Published: 2022
Journal Articles

Diagnosis-to-Treatment Interval Is an Important Prognostic Factor with a Time-Dependent Effect Predicting Event-Free Survival after 12 Months from First-Line Treatment in Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma

Marie-Charlotte Laude, Edith Julia, Emmanuelle Nicolas-Virelizier, MD, Gabriel Antherieu, Violaine Safar, Philippe Rey, MD, Emmanuelle Ferrant, MD, Alexandra Traverse-Glehen, MD PhD, Catherine Chassagne-Clément, MD, David Meyronet, MD PhD, Anne Lazareth, MD, Helene Lequeu, MD, Camille Golfier, MD, Gabriel Brisou, MD, Dana Ghergus, MD, Pierre Sesques, MD, Lionel Karlin, MD, Gilles Salles, MDPhD, Emmanuel Bachy, MD PhD, François Ducray, MD PhD, Fadhela Bouafia, MD, Youenn Drouet, PhD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–45.
https://doi.org/10.1182/blood-2020-138789
Published: 2020
Journal Articles

Retrospective Evaluation of Rituximab, Methotrexate, Procabazine, Vincristine and Etoposide Followed By Consolidation with Rituximab, Aracytine and Ifosfamide for Elderly Patients with Newly Diagnosed Primary CNS Lymphoma

Gabriel Antherieu, PhD, Edith Julia, Emmanuelle Nicolas-Virelizier, MD, Marie-Charlotte Laude, Violaine Safar, Philippe Rey, MD, Emmanuelle Ferrant, MD, Alexandra Traverse-Glehen, MD PhD, Catherine Chassagne-Clément, MD, David Meyronet, MD PhD, Anne Lazareth, MD, Helene Lequeu, MD, Camille Golfier, MD, Gabriel Brisou, MD, Dana Ghergus, MD, Pierre Sesques, MD, Lionel Karlin, MD, Fadhela Bouafia, MD, Gilles Salles, MDPhD, Emmanuel Bachy, MD PhD, François Ducray, MD PhD, Youenn Drouet, PhD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-139946
Published: 2020
Journal Articles

Prospective, Multicentric Phase II Randomized Trial Comparing the Efficacy of Methotrexate or Cyclophosphamide in Large Granular Lymphocytic Leukemia: A French National Study. Report on the Interim Analysis

Thierry Lamy, PhD MD, Cedric Pastoret, MD, Roch Houot, MD PhD, Loic Ysebaert, MD PhD, Mathilde Hunault, MD PhD, Gandhi Damaj, Anne Banos, Olivier Tournilhac, Bachra Choufi, Jean-Pierre Marolleau, MD PhD, Jehan Dupuis, MD, Alain Jacques Delmer, MD PhD, Stephane Lepretre, Emmanuel Gyan, MD PhD, Pierre Feugier, MD PhD, Sophie Rigaudeau, MD, Anne Lazareth, MD, Jean Valère Malfuson, MD, Thierry Fest, Eric Bellissant
Journal: Blood
Blood (2019) 134 (Supplement_1): 1545.
https://doi.org/10.1182/blood-2019-123439
Published: 2019
Journal Articles

Ritumixab in Combination with Adapted-Dose of Ifosfamide and Etoposide As Salvage Treatment in Elderly Refractory/Relapsed Diffuse Large B-Cell Lymphoma Patients Non-Candidate for High Dose Therapy: A Retrospective Study of Lyon Hospital University

Guillaume Aussedat, Delphine Maucort-Boulch, MD PhD, Philippe Rey, MD, Violaine Safar, MD, Lionel Karlin, MD, Mad-Helenie Elsensohn, Msc, Laure Lebras, MD, Clementine Sarkozy, MD, Emmanuel Bachy, MD PhD, Bertrand Favier, PharmD, PhD, Nicolas Vantard, PharmD, Pierre Sesques, MD, Anne Lazareth, MD, Emmanuelle Ferrant, MD, Dana Ghergus, MD, Gilles Salles, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4215.
https://doi.org/10.1182/blood-2018-99-116734
Published: 2018
Journal Articles

A New Simplified Prognostic Index Integrating the Type of Extra-Nodal Involvement and Age for Ann Arbor Stage IV Hodgkin Lymphoma Patients Diagnosed at TEP-Scanner Era: A Retrospective Analysis from Lymphoma Study Association (LYSA) Centers

Camille Golfier, Delphine Maucort-Boulch, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Cedric Rossi, MD, Pierre Sesques, MD, Nicolas Vantard, PharmD, Bertrand Favier, PharmD, PhD, Emmanuel Bachy, MD PhD, Florence Broussais-Guillaumot, MD, Emmanuelle Ferrant, MD, Dana Ghergus, MD, Lionel Karlin, MD, Anne Lazareth, MD, Violaine Safar, MD, Clementine Sarkozy, MD, Souad Assaad, MD, Laure Lebras, MD, Philippe Rey, MD, Jean-Noel Bastie, MD PhD, Alexandra Traverse-Glehen, MD PhD, Laurent Martin, MD PhD, Jeremie Tordo, MD, Alina Berriolo-Riedinger, MD, Gilles Salles, MD PhD, Rene-Olivier Casasnovas, MD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1629.
https://doi.org/10.1182/blood-2018-99-118578
Published: 2018
Journal Articles

A Prospective Phase II Trial of Lenalidomide and Dexamethasone ( LEN-DEX) in POEMS Syndrome

Arnaud Jaccard, MD, Anne Lazareth, MD, Lionel Karlin, MD, Sylvain Choquet, MD, Laurent Frenzel, MD, Laurent Garderet, MD, Mamoun Dib, MD, Lionel Galicier, MD, Olivier Tournilhac, MD, Karim Belhadj, Philippe Moreau, MD, Olivier Decaux, MD PhD, Lotfi Benboubker, MD PhD, Michel Cogné, MD PhD, Lucile Musset, MD, Jean Paul Fermand, MD
Journal: Blood
Blood (2014) 124 (21): 36.
https://doi.org/10.1182/blood.V124.21.36.36
Published: 2014
Journal Articles

Clinical and Biological Features Of Multiple Myeloma (MM) and Monoclonal Gammopathies In Patients With Human Immunodeficiency Virus (HIV) Infection

Alexis Talbot, MD, Laurence Gérard, MD, Raphael Szalat, MD, David Boutboul, Stephanie Harel, MD, Anne Lazareth, Marion Malphettes, MD, PhD, Bouchra Asli, MD, Lionel Galicier, MD, Claire Fieschi, MD, PhD, Eric Oksenhendler, MD, Jean Paul Fermand, MD, Bertrand Arnulf, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5348.
https://doi.org/10.1182/blood.V122.21.5348.5348
Published: 2013
Journal Articles

Prognostic Value of the Different MMSET Gene Breakpoints and Correlation with Immunoglobulin Isotype and FGFR3 Expression in 173 Patients with t(4;14) Multiple Myeloma

Bertrand Arnulf, MD, PhD, Anne Lazareth, Jean Soulier, MD, PhD, Stephanie Harel, MD, Lionel Karlin, MD, Damien Roosweil, Karim Belhadj, Jerome Tamburini, Arnaud Jaccard, Raphael Szalat, Bouchra Asli, MD, Marion Malphettes, MD, PhD, jean Christophe Bories, Jean Paul Fermand, MD
Journal: Blood
Blood (2012) 120 (21): 3971.
https://doi.org/10.1182/blood.V120.21.3971.3971
Published: 2012
Journal Articles

Characteristics and Outcome of MDS with Isolated Del 20q: The GFM Experience in 64 Cases.

Thorsten Braun, Stephane de Botton, Anne-Laure Taksin, Sophie Park, Odile Beyne-Rauzy, Sylvie Chevret, Michaela Fontenay, Bruno Cassinat, Anne Lazareth, Virginie Eclache, Chrisitine Terre, Norbert Vey, Agnes Guerci, Francois Dreyfus, Dominique Bordessoule, Aspasia Stamatoullas, Sylvie Castaigne, Pierre Fenaux, Lionel Ades
Journal: Blood
Blood (2008) 112 (11): 1657.
https://doi.org/10.1182/blood.V112.11.1657.1657
Published: 2008